Kintara Declares a Reverse One-for-Fifty Stock Split
A 1-for-50 reverse stock split of its outstanding and authorised common stock will be implemented by Kintara Therapeutics, Inc. (Nasdaq: KTRA), a biopharmaceutical company focused GO→
A 1-for-50 reverse stock split of its outstanding and authorised common stock will be implemented by Kintara Therapeutics, Inc. (Nasdaq: KTRA), a biopharmaceutical company focused GO→